Effect of Directly Observed Therapy for Highly Active Antiretroviral Therapy on Virologic, Immunologic, and Adherence Outcomes: A Meta-Analysis and Systematic ReviewHART, Jessica E; JEON, Christie Y; IVERS, Louise C et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 2, pp 167-179, issn 1525-4135, 13 p.Article

Risk of Viral Failure Declines With Duration of Suppression on Highly Active Antiretroviral Therapy Irrespective of Adherence LevelLIMA, Viviane D; BANGSBERG, David R; HARRIGAN, P. Richard et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 4, pp 460-465, issn 1525-4135, 6 p.Article

Cost-Effectiveness of Using HAART in Prevention of Mother-To-Child Transmission in the DREAM-Project MalawiORLANDO, Stefano; MARAZZI, Maria Cristina; MANCINELLI, Sandro et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 5, pp 631-634, issn 1525-4135, 4 p.Article

The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over TimeLIMA, Viviane D; HARRIGAN, Richard; BANGSBERG, David R et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 5, pp 529-536, issn 1525-4135, 8 p.Article

Physician specialization and antiretroviral therapy for HIV: Adoption and use in a national probability sample of persons infected with HIVLONDON, Bruce E; WILSON, Ira B; COHN, Susan E et al.Journal of general internal medicine. 2003, Vol 18, Num 4, pp 233-241, issn 0884-8734, 9 p.Article

Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patientsMCNAGHTEN, A. D; HANSON, Debra L; DWORKIN, Mark S et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 32, Num 5, pp 499-505, issn 1525-4135, 7 p.Article

Evaluation of a Systematic Substitution of Zidovudine for Stavudine-Based HAART in a Program Setting in Rural CambodiaISAAKIDIS, Petros; RAGUENAUD, Marie-Eve; PHE, Thong et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 1, pp 48-54, issn 1525-4135, 7 p.Article

Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patientsOSTROWSKI, Sisse R; KATZENSTEIN, Terese L; PIIRONEN, Timo et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, Num 4, pp 337-342, issn 1525-4135, 6 p.Article

Independent Effects of HIV, Aging, and HAART on Brain Volumetric MeasuresANCES, Beau M; ORTEGA, Mario; VAIDA, Florin et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 5, pp 469-477, issn 1525-4135, 9 p.Article

Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With TuberculosisVELASCO, Maria; CASTILLA, Virgilio; SANZ, José et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 2, pp 148-152, issn 1525-4135, 5 p.Article

Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to CareWEINTROB, Amy C; GRANDITS, Greg A; AGAN, Brian K et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 5, pp 574-580, issn 1525-4135, 7 p.Article

Predictors for lower quality of life in the HAART era among HIV-infected menCHENGLONG LIU; JOHNSON, Lisette; OSTROW, David et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 4, pp 470-477, issn 1525-4135, 8 p.Article

Grade 4 events are as important as AIDS events in the era of HAARTREISLER, Ronald B; CONG HAN; BURMAN, William J et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, Num 4, pp 379-386, issn 1525-4135, 8 p.Article

Urinary Lipoarabinomannan as Predictor for the Tuberculosis Immune Reconstitution Inflammatory SyndromeCONESA-BOTELLA, Anali; MASSINGA LOEMBE, Marguerite; KESTENS, Luc et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 5, pp 463-468, issn 1525-4135, 6 p.Article

Deaths in the era of HAART : contribution of late presentation, treatment exposure, resistance and abnormal laboratory markersSABIN, Caroline A; SMITH, Colette J; YOULE, Mike et al.AIDS (London). 2006, Vol 20, Num 1, pp 67-71, issn 0269-9370, 5 p.Article

Increased incidence of disseminated histoplasmosis following highly active antiretroviral therapy initiationNACHER, Mathieu; SARAZIN, Frédérique; EL GUEDJ, Myriam et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 41, Num 4, pp 468-470, issn 1525-4135, 3 p.Article

Virologic, immunologic, and clinical response to Highly active antiretroviral therapy: The gender issue revisitedMOORE, Antonia L; KIRK, Ole; JOHNSON, Anne M et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 32, Num 4, pp 452-461, issn 1525-4135, 10 p.Article

The Association Between Primary Antiretroviral Resistance and HAART Virologic Failure in a Developing SetHENRIQUE GAGLIANI, Luiz; ALKMIM MAIA, Wagner T; SA-FILHO, Dercy et al.AIDS research and human retroviruses. 2011, Vol 27, Num 3, pp 251-256, issn 0889-2229, 6 p.Article

Variation of CD4 Count and Percentage during Pregnancy and after Delivery : Implications for HAART Initiation in Resource-Limited SettingsEKOUEVI, Didier K; INWOLEY, André; TONWE-GOLD, Besigin et al.AIDS research and human retroviruses. 2007, Vol 23, Num 12, pp 1469-1473, issn 0889-2229, 5 p.Article

Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapyBREEN, Ronan. A. M; MILLER, R. F; GORSUCH, T et al.The Journal of infectious diseases. 2006, Vol 193, Num 10, pp 1437-1440, issn 0022-1899, 4 p.Article

Hepatotoxicity of antiretroviral drugsABRESCIA, N; D'ABBRACCIO, M; FIGONI, M et al.Current pharmaceutical design. 2005, Vol 11, Num 28, pp 3697-3710, issn 1381-6128, 14 p.Article

Short-Term Discontinuation of HAART Regimens More Common in Vulnerable Patient PopulationsROBISON, Lindsay S; WESTFALL, Andrew O; MUGAVERO, Michael J et al.AIDS research and human retroviruses. 2008, Vol 24, Num 11, pp 1347-1355, issn 0889-2229, 9 p.Article

Drug Resistance and Viral Tropism in HIV-1 Subtype C-Infected Patients in KwaZulu-Natal, South Africa: Implications for Future Treatment OptionsSINGH, Ashika; SUNPATH, Henry; NDUNG'U, Thumbi et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 3, pp 233-240, issn 1525-4135, 8 p.Article

Implications of X4 tropic virus detection before HAART and disease progressionANSARI, Aftab A.AIDS (London). 2008, Vol 22, Num 4, pp 533-534, issn 0269-9370, 2 p.Article

Immunological Rebound after Initiation of Highly Active Antiretroviral Therapy in Treatment-Naive PatientsBLACKARD, Jason T; WELLES, Seth L; ACKERMAN, Avra et al.AIDS research and human retroviruses. 2008, Vol 24, Num 3, pp 499-504, issn 0889-2229, 6 p.Article